Literature DB >> 15972816

Identification of the amino acid residue of CYP27B1 responsible for binding of 25-hydroxyvitamin D3 whose mutation causes vitamin D-dependent rickets type 1.

Keiko Yamamoto1, Eriko Uchida, Naoko Urushino, Toshiyuki Sakaki, Norio Kagawa, Natsumi Sawada, Masaki Kamakura, Shigeaki Kato, Kuniyo Inouye, Sachiko Yamada.   

Abstract

We previously reported the three-dimensional structure of human CYP27B1 (25-hydroxyvitamin D3 1alpha-hydroxylase) constructed by homology modeling. Using the three-dimensional model we studied the docking of the substrate, 25-hydroxyvitamin D3, into the substrate binding pocket of CYP27B1. In this study, we focused on the amino acid residues whose point mutations cause vitamin D-dependent rickets type 1, especially unconserved residues among mitochondrial CYPs such as Gln65 and Thr409. Recently, we successfully overexpressed mouse CYP27B1 by using a GroEL/ES co-expression system. In a mutation study of mouse CYP27B1 that included spectroscopic analysis, we concluded that in a 1alpha-hydroxylation process, Ser408 of mouse CYP27B1 corresponding to Thr409 of human CYP27B1 forms a hydrogen bond with the 25-hydroxyl group of 25-hydroxyvitamin D3. This is the first report that shows a critical amino acid residue recognizing the 25-hydroxyl group of the vitamin D3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972816     DOI: 10.1074/jbc.M505244200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylase.

Authors:  Grazia Chiellini; Simona Rapposelli; Jinge Zhu; Ilaria Massarelli; Marilena Saraceno; Anna Maria Bianucci; Lori A Plum; Margaret Clagett-Dame; Hector F DeLuca
Journal:  Steroids       Date:  2011-11-25       Impact factor: 2.668

2.  Structural motif-based homology modeling of CYP27A1 and site-directed mutational analyses affecting vitamin D hydroxylation.

Authors:  David E Prosser; Yuding Guo; Zongchao Jia; Glenville Jones
Journal:  Biophys J       Date:  2006-02-24       Impact factor: 4.033

3.  Mutation prediction by PolyPhen or functional assay, a detailed comparison of CYP27B1 missense mutations.

Authors:  Minjing Zou; Essa Y Baitei; Ali S Alzahrani; Ranjit S Parhar; Futwan A Al-Mohanna; Brian F Meyer; Yufei Shi
Journal:  Endocrine       Date:  2011-05-21       Impact factor: 3.633

4.  In vivo evidence for a novel pathway of vitamin D₃ metabolism initiated by P450scc and modified by CYP27B1.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Haleem Z Shehabi; Igor Semak; Edith K Y Tang; Minh N Nguyen; Heather A E Benson; Elena Korik; Zorica Janjetovic; Jianjun Chen; Charles R Yates; Arnold Postlethwaite; Wei Li; Robert C Tuckey
Journal:  FASEB J       Date:  2012-06-08       Impact factor: 5.191

5.  A novel CYP27B1 mutation causes a feline vitamin D-dependent rickets type IA.

Authors:  Robert A Grahn; Melanie R Ellis; Jennifer C Grahn; Leslie A Lyons
Journal:  J Feline Med Surg       Date:  2012-05-02       Impact factor: 2.015

6.  Cloning of a functional 25-hydroxyvitamin D-1α-hydroxylase in zebrafish (Danio rerio).

Authors:  Rene F Chun; Elizabeth Blatter; Stephanie Elliott; Sorel Fitz-Gibbon; Sandra Rieger; Alvaro Sagasti; John S Adams; Martin Hewison
Journal:  Cell Biochem Funct       Date:  2014-10-07       Impact factor: 3.685

7.  Structural evidence for enhancement of sequential vitamin D3 hydroxylation activities by directed evolution of cytochrome P450 vitamin D3 hydroxylase.

Authors:  Yoshiaki Yasutake; Yoshikazu Fujii; Taiki Nishioka; Woo-Kwang Cheon; Akira Arisawa; Tomohiro Tamura
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

8.  Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1.

Authors:  Edith K Y Tang; Jianjun Chen; Zorica Janjetovic; Elaine W Tieu; Andrzej T Slominski; Wei Li; Robert C Tuckey
Journal:  Drug Metab Dispos       Date:  2013-03-01       Impact factor: 3.922

9.  Mutation update and long-term outcome after treatment with active vitamin D3 in Chinese patients with pseudovitamin D-deficiency rickets (PDDR).

Authors:  Y Chi; J Sun; L Pang; R Jiajue; Y Jiang; O Wang; M Li; X Xing; Y Hu; X Zhou; X Meng; W Xia
Journal:  Osteoporos Int       Date:  2018-10-31       Impact factor: 4.507

10.  Identification of kinase inhibitors that rule out the CYP27B1-mediated activation of vitamin D: an integrated machine learning and structure-based drug designing approach.

Authors:  Kanupriya Mahajan; Himanshu Verma; Shalki Choudhary; Baddipadige Raju; Om Silakari
Journal:  Mol Divers       Date:  2021-07-16       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.